President & CEO, Linical USA
Core values of Integrity, Enthusiasm, and Spirit of Inquiry
On average, the global CRO market is growing at an annual rate of over 6%, and by 2022 it is expected to reach a value of 4.52 billion USD. The USA is currently the biggest market in the global CRO industry, accounting for over 40% of total sales. To become a true strategic partner of pharmaceutical companies, Linical has grown steadily over the years, under the slogan “Japanese Headquartered Global CRO”. It took its first step to becoming a global CRO in 2008, when it established Linical USA, Inc., which has pursued a variety of business activities, focused on regulatory affairs-related consulting, project management, and monitoring. We firmly believe that the strong growth of Linical USA is the result of employing “the right people” — clinical development professionals who can provide clients with high value-added services and who resonate with our core values of “Integrity”, “Enthusiasm”, and “Spirit of Inquiry”, which correspond to the blue, red, and yellow colors of our tricolor logo. We have steadily assembled a team of “pioneers” who can work together to blaze a trail through the US market in the years ahead.
Creating a totally new kind of value
Our US staff boasts a high level of productivity and is blessed with numerous individuals capable of leading and driving the CRO industry forward. By blending these qualities with the traditional Japanese qualities of precision, quality consciousness, and customer care that Linical has fostered, we are confident of creating a totally new kind of value. To realize the mission of the Linical Group — “to become a think tank specializing in clinical trials (a CRO that provides know-how)” — in the US as well as Asia, we will evolve together with “the right people” and combine the forces of the entire Group to offer a one-stop set of unrivalled services.